IPO pricing expected within 1-2 days. Monitor the final offering price and any updates on the $10M Catalyze product rights payment. The resale overhang and severe revenue decline suggest significant downside risk post-IPO.
Price Chart
Executive Summary
BioStem Technologies' S-1 registration (File No. 333-299025) became effective on September 29, 2026, allowing the company to proceed with its IPO. The registration covers the resale of up to 3,571,429 shares by selling stockholder Pleiades Partners LLC, stemming from a May 2026 private placement. The company faces severe financial headwinds including a 62% YoY revenue decline and a going-concern opinion, making this a high-risk IPO.
Key Facts
- S-1 registration became effective on September 29, 2026 (File No. 333-299025)
- Registration covers resale of up to 3,571,429 shares by Pleiades Partners LLC
- Shares originate from a May 2026 private placement
- Prior S-1 filing (July 29, 2026) disclosed 62% YoY revenue decline to $6.1M in Q1 2026
- Net loss of $8.8M in Q1 2026 vs. $3.9M profit in Q1 2025
- Going-concern opinion from auditor due to $21.2M accumulated deficit and $10M Catalyze payment obligation
- CMS reimbursement change cut revenue per square centimeter by up to 95% effective January 1, 2026
Financial Impact
Up to 3,571,429 shares of potential overhang from resale registration; company reported 62% YoY revenue decline and $8.8M net loss in Q1 2026
Risk Factors
- Massive dilution from resale registration of 3.57M shares by Pleiades Partners
- Going-concern risk with $21.2M accumulated deficit and $10M near-term payment obligation
- Core physician-office business devastated by CMS reimbursement change (up to 95% revenue per cm² cut)
- Potential anti-dilution issuance at $0.70/share further diluting existing holders
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003103 |
| Document: 9999999995-26-003103-index.html | 9999999995-26-003103 |
| Document: 9999999995-26-003103.txt | 9999999995-26-003103 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | EFFECT | $2.25 $2.11 | ▲ +6.22% | ▲ +5.14% | $1.54 (+31.56%) |
Oct 2, 2026 24d ago | S-1 | $2.76 $2.47 | ▲ +10.34% | ▲ +10.89% | $1.54 (+44.10%) |
Sep 30, 2026 26d ago | 8-K | $3.07 $2.73 | ▲ +11.07% | ▲ +11.81% | $1.54 (+49.84%) |
Sep 30, 2026 26d ago | EFFECT | $3.09 $3.07 | ▲ +0.65% | ▲ +0.83% | $1.54 (+50.16%) |
Sep 21, 2026 5w ago | Press Release | $3.98 $3.80 | ▼ −4.52% | ▼ −3.80% | $1.54 (−61.31%) |
Sep 18, 2026 5w ago | S-1 | $4.40 $3.98 | ▲ +9.55% | ▲ +9.53% | $1.54 (+65.00%) |
Sep 18, 2026 5w ago | Press Release | $4.74 $4.40 | ▲ +7.17% | ▲ +8.72% | $1.54 (+67.51%) |
Aug 14, 2026 10w ago | 3 | $3.00 $3.15 | ▲ +5.00% | ▲ +5.68% | $1.54 (−48.67%) |
Aug 14, 2026 10w ago | 3 | $3.00 $3.15 | ▲ +5.00% | ▲ +5.68% | $1.54 (−48.67%) |
Jul 29, 2026 12w ago | S-1 | $3.29 $3.20 | ▲ +2.74% | ▲ +4.41% | $1.54 (+53.19%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers